atezolizumab
roche
['atezo', 'renal,(-adrenal)']
adjuvant atezolizumab does not show benefit over placebo in high risk renal cancer for dfs/os. presented at #esmo2022 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"